Shared Decision Making in Diabetes Prevention for Women With a History of GDM
Pilot Study of Pharmacist-Coordinated Implementation of the Diabetes Prevention Program (DPP) for Women With a History of Gestational Diabetes Mellitus (GDM)
1 other identifier
interventional
33
1 country
20
Brief Summary
Gestational diabetes mellitus (GDM) is a risk factor for the development of Type 2 diabetes. Lifestyle change and metformin are equally effective in preventing diabetes in patients with a history of GDM, so these women should choose a strategy based on their preferences and values, which may vary by race/ethnicity. This proposal will engage 32 women in shared decision making about diabetes prevention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2019
Shorter than P25 for not_applicable
20 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2018
CompletedFirst Posted
Study publicly available on registry
December 6, 2018
CompletedStudy Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 28, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2019
CompletedFebruary 21, 2020
February 1, 2020
10 months
November 5, 2018
February 19, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Choice of evidence-based diabetes prevention (lifestyle change or metformin)
One of four participant decisions: 1) choosing to attend a Centers for Disease Control and Prevention (CDC)-certified diabetes prevention program, 2) choosing to start metformin as diabetes prevention, 3) choosing both the diabetes prevention program and metformin, 4) choosing NOT to start either the diabetes prevention program or start metformin.
2 weeks
Secondary Outcomes (3)
Weight change
9 months
Systolic blood pressure
9 months
Decisional conflict
2 weeks
Study Arms (1)
Shared decision-making with pharmacists
EXPERIMENTALPharmacist-coordinated shared decision making about treatment for history of gestational diabetes mellitus (lifestyle change and/or metformin), using a decision tool
Interventions
Pharmacist will engage patient with history of gestational diabetes mellitus using Healthwise (TM) Decision Tool to help match their personal preferences and values with treatment options, specifically lifestyle change will be referred to a CDC (Center for Disease Control and Prevention) approved diabetes prevention program, and pharmacists will coordinate with primary care providers to prescribe metformin for patients interested in this treatment.
Eligibility Criteria
You may qualify if:
- Overweight or obese (BMI \>25 or \>23 if Asian American)
- at least 6 weeks post-partum
- have a history of gestational diabetes mellitus
You may not qualify if:
- Currently pregnant,
- not a UCLA Health patient
- any history of a Type 2 diabetes diagnosis, based on billing codes, laboratory values, or taking any antiglycemic medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (20)
Toluca Lake Health Center
Burbank, California, 91505, United States
100 Medical Plaza Primary Care Suites 455 & 490
Los Angeles, California, 90024, United States
Internal Medicine Women's Health Clinic Suites 250 & 290
Los Angeles, California, 90024, United States
UCLA Internal Medicine Family Westwood Suite 465
Los Angeles, California, 90024, United States
UCLA Internal Medicine Geriatrics Suite 365 & 420
Los Angeles, California, 90024, United States
CPN Brentwood
Los Angeles, California, 90049, United States
CPN West Washington Internal Medicine
Los Angeles, California, 90066, United States
Pacific Palisades
Pacific Palisades, California, 90272, United States
12th Street Clinic
Santa Monica, California, 90401, United States
Wilshire Office
Santa Monica, California, 90401, United States
CPN Santa Monica 15th Street Family Medicine Practice
Santa Monica, California, 90404, United States
CPN/Santa Monica Parkside
Santa Monica, California, 90404, United States
Santa Moica Bay Physicians/20th Street 10th Floor
Santa Monica, California, 90404, United States
Santa Monica Bay Physicians Plaza
Santa Monica, California, 90404, United States
Santa Monica Bay Physicians/20th Street 3rd Floor
Santa Monica, California, 90404, United States
Santa Monica Internal Medicine
Santa Monica, California, 90404, United States
UCLA Family Health Clinic
Santa Monica, California, 90404, United States
Santa Moica Bay Physicians Ocean Park
Santa Monica, California, 90405, United States
Jack H. Skirball Health Center
Woodland Hills, California, 91364, United States
CPN Woodland Hills Practice
Woodland Hills, California, 91367, United States
Related Publications (1)
Madievsky R, Vu A, Cheng F, Chon J, Turk N, Krueger A, Krong J, Maranon R, Liu S, Han CS, Norris KC, Mangione C, Page J, Thomas S, Duru OK, Moin T. A randomized controlled trial of a shared decision making intervention for diabetes prevention for women with a history of gestational diabetes mellitus: The Gestational diabetes Risk Attenuation for New Diabetes (GRAND study). Contemp Clin Trials. 2023 Jan;124:107007. doi: 10.1016/j.cct.2022.107007. Epub 2022 Nov 13.
PMID: 36384219DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
November 5, 2018
First Posted
December 6, 2018
Study Start
March 1, 2019
Primary Completion
December 28, 2019
Study Completion
December 28, 2019
Last Updated
February 21, 2020
Record last verified: 2020-02